4 results match your criteria: "Aerospace Center Hospital and Peking university aerospace School of Clinical Medicine[Affiliation]"
Impacts of exposure to ambient temperature and altitude on the burden of stroke.
J Neurol
September 2023
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119, South Four Ring West Road, Beijing, 100070, People's Republic of China.
Objective: To evaluate the impact of ambient temperature and altitude exposure on the burden of stroke in a Chinese cohort.
Methods: This study was conducted using data from the National Stroke High-Risk Population Screening System 2020, which assess the overall prevalence, incidence, and mortality rate of stroke in China. For this study, we obtained the annual mean ambient temperature, diurnal temperature range, and altitude for each city.
Intravenous Thrombolysis or Medical Management for Minor Strokes.
Thromb Haemost
July 2023
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
Objective: To evaluate the outcomes of acute ischemic stroke patients with minor deficits treated with either intravenous thrombolysis (IVT) or routine medical management (MM).
Methods: The study included patients with acute ischemic stroke and National Institutes of Health Stroke Scale (NIHSS) scores of 5 or less who were treated with IVT within 4.5 hours from symptom onset and were classified as the IVT group.
A response to a letter to the editor TR-D-22-00887.
Thromb Res
March 2023
Department of Neurology, Aerospace Center Hospital and Peking University Aerospace School of Clinical Medicine, Beijing, China.
Impact of the COVID-19 pandemic lockdown on hospitalizations for cerebrovascular disease and related in-hospital mortality in China: A nationwide observational study.
Arch Gerontol Geriatr
January 2023
Department of Neurology, Aerospace Center Hospital and Peking university aerospace School of Clinical Medicine, NO.15, Yuquan Road, Beijing 100049, China. Electronic address:
Background And Purpose: The aim of this nationwide study was to assess the impact of the COVID-19 pandemic on cerebrovascular disease hospitalization rates, out-of-pocket rates, and in-hospital case fatality rates.
Methods: All hospitalizations for cerebrovascular disease from 1599 hospitals from 2019 to 2020 were selected using the International Classification of Diseases, 10th revision, in the Hospital Quality Monitoring System (HQMS). We defined 2019 as the pre-pandemic group and 2020 as the post-pandemic group.